Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronique Neumeister

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
JAMA Oncology|August 20, 2016
A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1Patricia Gaule, James W Smithy, Maria Toki, et al.
NPJ Breast Cancer|September 5, 2019
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancerSwati Gupta, Veronique Neumeister, John McGuire, et al.
Oral Oncology|March 31, 2019
PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinomaNnamdi Eze, Ju-Whei Lee, Dong-Hua Yang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 12, 2017
High concordance of a closed-system, RT-qPCR breast cancer assay for HER2 mRNA, compared to clinically determined immunohistochemistry, fluorescence in situ hybridization, and quantitative immunofluorescenceBrad E Wasserman, Daniel E Carvajal-Hausdorf, Kenneth Ho, et al.
Head & Neck|April 1, 2025
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckAarti Bhatia, Ranee Mehra, Jessica Bauman, et al.
Integrative Cancer Therapies|November 29, 2022
The Effect of Black Cohosh on Ki67 expression and Tumor Volume: A Pilot Study of Ductal Carcinoma in Situ PatientsAmelia A Trant, Anees Chagpar, Wei Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805Lucia B Jilaveanu, Maneka Puligandla, Sarah A Weiss, et al.
JCI Insight|December 8, 2020
MicroRNA miR-24-3p reduces DNA damage responses, apoptosis, and susceptibility to chronic obstructive pulmonary diseaseJessica Nouws, Feng Wan, Eric Finnemore, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
JAMA Oncology|August 20, 2016
A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1Patricia Gaule, James W Smithy, Maria Toki, et al.
NPJ Breast Cancer|September 5, 2019
Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancerSwati Gupta, Veronique Neumeister, John McGuire, et al.
Oral Oncology|March 31, 2019
PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinomaNnamdi Eze, Ju-Whei Lee, Dong-Hua Yang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 12, 2017
High concordance of a closed-system, RT-qPCR breast cancer assay for HER2 mRNA, compared to clinically determined immunohistochemistry, fluorescence in situ hybridization, and quantitative immunofluorescenceBrad E Wasserman, Daniel E Carvajal-Hausdorf, Kenneth Ho, et al.
Head & Neck|April 1, 2025
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckAarti Bhatia, Ranee Mehra, Jessica Bauman, et al.
Integrative Cancer Therapies|November 29, 2022
The Effect of Black Cohosh on Ki67 expression and Tumor Volume: A Pilot Study of Ductal Carcinoma in Situ PatientsAmelia A Trant, Anees Chagpar, Wei Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805Lucia B Jilaveanu, Maneka Puligandla, Sarah A Weiss, et al.
JCI Insight|December 8, 2020
MicroRNA miR-24-3p reduces DNA damage responses, apoptosis, and susceptibility to chronic obstructive pulmonary diseaseJessica Nouws, Feng Wan, Eric Finnemore, et al.
Pageof 2